Received May 8, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPVHIB | DTAP + IPV + HIB (PENTACEL) | SANOFI PASTEUR | UNK | — | — |
| RV5 | ROTAVIRUS (ROTATEQ) | MERCK & CO. INC. | UNK | 2164395 | OT |
TE for ROTATEQ and Pentacel; No adverse effects reported; This spontaneous report was received from a pharmacy technician and refers to a patient of unknown gender and age. The patient's concurrent conditions, medical history and concomitant therapies were not provided. On an unknown date, the patient was vaccinated with rotavirus vaccine (ROTATEQ) orally lot # 2164395, expiration date 22-MAR-2027 (dose was not provided) and Diphtheria vaccine toxoid (+) HIB vaccine conj (tet tox) (+) Pertussis vaccine acellular 5-component (+) Polio vaccine inact 3v (MRC 5 (+) Tetanus vaccine toxoid (PENTACEL) (dose, route of administration, anatomical location, lot # and expiration date were not provided) for prophylaxis. Both suspect vaccines were improperly stored (Product storage issue). No details provided. No adverse effects were reported. This is one of 4 reports derived from the same reporter.